Senator John Boozman (R-Arkansas) recently sold shares of Lam Research Corporation (NASDAQ:LRCX). In a filing disclosed on February 15th, the Senator disclosed that they had sold between $1,001 and $15,000 in Lam Research stock on January 8th.
Senator John Boozman also recently made the following trade(s):
- Sold $1,001 – $15,000 in shares of Omnicom Group (NYSE:OMC) on 1/29/2026.
- Purchased $1,001 – $15,000 in shares of Eaton (NYSE:ETN) on 1/29/2026.
- Purchased $1,001 – $15,000 in shares of Caterpillar (NYSE:CAT) on 1/29/2026.
- Sold $1,001 – $15,000 in shares of iShares S&P 500 Growth ETF (NYSEARCA:IVW) on 1/29/2026.
- Sold $1,001 – $15,000 in shares of Fiserv (NASDAQ:FISV) on 1/29/2026.
- Sold $1,001 – $15,000 in shares of Union Pacific (NYSE:UNP) on 1/29/2026.
- Purchased $1,001 – $15,000 in shares of CVS Health (NYSE:CVS) on 1/29/2026.
- Purchased $1,001 – $15,000 in shares of PayPal (NASDAQ:PYPL) on 1/29/2026.
- Purchased $1,001 – $15,000 in shares of DexCom (NASDAQ:DXCM) on 1/26/2026.
- Sold $1,001 – $15,000 in shares of Micron Technology (NASDAQ:MU) on 1/26/2026.
Lam Research Price Performance
Shares of LRCX stock opened at $244.92 on Friday. The stock’s fifty day simple moving average is $209.11 and its 200 day simple moving average is $159.86. Lam Research Corporation has a one year low of $56.32 and a one year high of $251.87. The firm has a market cap of $305.85 billion, a price-to-earnings ratio of 50.19, a P/E/G ratio of 2.55 and a beta of 1.78. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.26 and a quick ratio of 1.61.
Lam Research Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a dividend yield of 0.4%. The ex-dividend date is Wednesday, March 4th. Lam Research’s dividend payout ratio (DPR) is 21.31%.
Hedge Funds Weigh In On Lam Research
Several large investors have recently bought and sold shares of the business. Lingohr Asset Management GmbH raised its holdings in shares of Lam Research by 590.7% in the third quarter. Lingohr Asset Management GmbH now owns 59,555 shares of the semiconductor company’s stock valued at $7,974,000 after purchasing an additional 50,933 shares during the last quarter. Mediolanum International Funds Ltd increased its position in shares of Lam Research by 52.0% in the third quarter. Mediolanum International Funds Ltd now owns 262,544 shares of the semiconductor company’s stock valued at $34,417,000 after acquiring an additional 89,856 shares during the last quarter. First Citizens Bank & Trust Co. raised its holdings in Lam Research by 8.0% during the third quarter. First Citizens Bank & Trust Co. now owns 140,433 shares of the semiconductor company’s stock worth $18,804,000 after acquiring an additional 10,408 shares in the last quarter. Oregon Public Employees Retirement Fund boosted its position in Lam Research by 30.9% during the third quarter. Oregon Public Employees Retirement Fund now owns 144,656 shares of the semiconductor company’s stock valued at $19,369,000 after purchasing an additional 34,147 shares during the last quarter. Finally, Truist Financial Corp grew its stake in Lam Research by 119.6% in the third quarter. Truist Financial Corp now owns 1,676,637 shares of the semiconductor company’s stock valued at $224,502,000 after purchasing an additional 913,009 shares in the last quarter. 84.61% of the stock is currently owned by institutional investors and hedge funds.
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: TD Cowen raised its price target sharply to $290 (from $170) and kept a Buy rating, highlighting the large 2026 WFE market opportunity that benefits Lam. Is Lam Research (LRCX) One of the Best Growth Stocks to Buy for the Next 20 Years?
- Positive Sentiment: BofA’s Vivek Arya named Lam his top semiconductor-equipment pick, citing a projected ~$135B industry spending surge in 2026 as AI demand forces multi-year factory investment — a direct tailwind for Lam’s tools. Lam Research Named Top Semiconductor Pick As AI-Driven Manufacturing Supercycle Shifts Into High Gear
- Positive Sentiment: Lam’s Boise expansion strengthens its operational ties with Micron and positions the company to capture increased demand for AI memory production equipment. This local expansion is being read as evidence of customers ramping capacity. Lam Research Boise Expansion Deepens Micron Ties In AI Memory Cycle
- Positive Sentiment: Multiple bullish write-ups argue Lam has durable growth attributes that could drive strong multi-year returns, reinforcing investor conviction around the AI/memory-driven cycle. 3 Reasons Growth Investors Will Love Lam Research (LRCX) 3 Reasons Growth Investors Will Love Lam Research (LRCX) Is Lam Research (LRCX) One of the Best Growth Stocks to Buy for the Next 20 Years?
- Neutral Sentiment: A report about Japan’s Toto (a supplier to chip-equipment makers) and activist interest may signal broader supply‑chain positioning for chip-equipment suppliers, but it’s peripheral to Lam’s core demand drivers. This Toilet Stock Is Surging as an AI Bet. An Activist Sees More Gains.
- Neutral Sentiment: Two short-interest data entries in the feed show zero or inconsistent values (0 shares / NaN), which appears to be a reporting/data issue rather than a meaningful change in betting against the stock. Monitor reliable short-interest releases for any real pressure.
- Neutral Sentiment: Articles discussing the evolving Lam narrative compile the above themes (upgraded targets, expansion, AI cycle) — useful context but largely reiterative rather than new catalysts. How The Narrative Around Lam Research (LRCX) Is Evolving With New Forecasts And Expansion Moves
Insiders Place Their Bets
In related news, Director Eric Brandt sold 35,000 shares of the business’s stock in a transaction on Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the transaction, the director directly owned 253,705 shares in the company, valued at approximately $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.31% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on the stock. Summit Insights upgraded shares of Lam Research from a “hold” rating to a “buy” rating in a research report on Thursday, January 29th. Jefferies Financial Group reaffirmed a “buy” rating and set a $200.00 price objective (up previously from $175.00) on shares of Lam Research in a report on Monday, December 15th. Stifel Nicolaus lifted their target price on shares of Lam Research from $250.00 to $280.00 and gave the company a “buy” rating in a research note on Thursday, January 29th. Royal Bank Of Canada restated an “outperform” rating and set a $290.00 price target (up from $260.00) on shares of Lam Research in a research report on Thursday, January 29th. Finally, Susquehanna set a $325.00 price target on Lam Research and gave the company a “positive” rating in a report on Thursday, January 29th. One research analyst has rated the stock with a Strong Buy rating, twenty-eight have issued a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $244.88.
View Our Latest Report on LRCX
About Senator Boozman
John Boozman (Republican Party) is a member of the U.S. Senate from Arkansas. He assumed office on January 3, 2011. His current term ends on January 3, 2029. Boozman (Republican Party) ran for re-election to the U.S. Senate to represent Arkansas. He won in the general election on November 8, 2022. Boozman won re-election in 2016. He faced Democrat Conner Eldridge, Libertarian Frank Gilbert, and write-in candidate Jason Tate in the general election. Arkansas’ U.S. Senate race was rated as safely Republican in 2016. Boozman began his political career in the U.S. House. He won a special election in 2001 and served in that position until his election to the Senate in 2010. Prior to his political career, Boozman worked as an optometrist. As of a 2014 analysis of multiple outside rankings, Boozman is an average Republican member of Congress, meaning he will vote with the Republican Party on the majority of bills. Below is an abbreviated outline of Boozman’s academic, professional, and political career: 2011-Present: U.S. Senator from Arkansas 2001-2011: U.S. Representative from Arkansas 1977: Graduated from Southern College of Optometry
About Lam Research
Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
See Also
- Five stocks we like better than Lam Research
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- New gold price target
Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.
